Sepsis Diagnostics Market To Reach $874.6 Million By 2025: Grand View Research, Inc
The global sepsis diagnostics market is expected to reach a
value of USD 874.6 million by 2025, according to a new report by Grand View
Research, Inc. Rising prevalence of sepsis is the most significant factor
anticipated to drive the market growth during the forecast period.
According to the National Center for Biotechnology Information,
the number of patients suffering from septic poisoning rose by an average of
5.7% each year. As a result of this, there is a rising need for early diagnosis
of such blood-poisoning diseases amongst patients. High prevalence of sepsis is
also leading to a huge mortality rate, which is triggering early diagnosis to
execute the clinical intervention.
Rising number of hospital-acquired infections are also
expected to support the growth of the market over the forecast period.
Hospital-acquired infections majorly include urinary tract & surgical site
infections, which result into sepsis. According to WHO, 7 out of every 100
hospitalized patients develop hospital-acquired infections in developed
countries. Thus, such infections significantly cause septicemia, which will
resultantly raise the need for early diagnosis. On the other hand, pneumonia is
also an important driving factor for high demand of sepsis diagnostics as it is
one of the major causes for septic shock.
Browse full research report on Sepsis Diagnostics Market: http://www.grandviewresearch.com/industry-analysis/sepsis-diagnostics-market
Further key findings from the study suggest:
- Blood
culture media was the largest segment in 2015 due to higher adoption of
culture media tests in laboratories for the diagnosis of septic poisoning
- Molecular
diagnostics is anticipated to witness lucrative growth over the forecast
period due to quick and efficient identification of microorganisms causing
septicemia
- Bacterial
sepsis contributed toward the largest revenue in 2015. This is due to the
fact that bacterial infection is the most common cause for people
suffering from septic poisoning
- In
2015, laboratory testing segment held the highest share due to the fact
that majority of the sepsis diagnostic tests are being conducted in
laboratory-based setting
- North
America dominated in 2015 owing to the increasing mortality rate of
patients suffering from septicemia
- Some
of the key companies include bioMérieux SA, Becton, Dickinson and Company,
Thermo Fisher Scientific Inc., Roche Diagnostics, Cepheid Inc., Beckman
Coulter, Inc., Nanosphere, Inc., and Bruker Corporation
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the sepsis diagnostics
market on the basis of product, technology, pathogen, testing type, and region:
Product Outlook (Revenue, USD Million; 2014 - 2025)
- Instruments
- Blood
Culture Media
- Assay
Kits and Reagents
Technology Outlook (Revenue, USD Million; 2014 - 2025)
- Microbiology
- Molecular
Diagnostics
- Immunoassays
- Flow
Cytometry
Pathogen Outlook (Revenue, USD Million; 2014 - 2025)
- Bacterial
Sepsis
- Gram-Positive
Bacteria
- Gram-Negative
Bacteria
- Fungal
Sepsis
- Others
Testing Type Outlook (Revenue, USD Million; 2014 -
2025)
- Laboratory
Testing
- PoC
Testing
Regional Outlook (Revenue, USD Million; 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-sepsis-diagnostics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
Comments
Post a Comment